Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Beam Therapeutics (BEAM) over the last 6 years, with Q3 2025 value amounting to 0.04.

  • Beam Therapeutics' Asset Utilization Ratio fell 8565.86% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 8565.86%. This contributed to the annual value of 0.05 for FY2024, which is 8162.28% down from last year.
  • As of Q3 2025, Beam Therapeutics' Asset Utilization Ratio stood at 0.04, which was down 8565.86% from 0.04 recorded in Q2 2025.
  • Beam Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.29 during Q3 2024, with a 5-year trough of 0.0 in Q2 2021.
  • For the 5-year period, Beam Therapeutics' Asset Utilization Ratio averaged around 0.09, with its median value being 0.05 (2022).
  • In the last 5 years, Beam Therapeutics' Asset Utilization Ratio surged by 17692934.48% in 2022 and then tumbled by 8565.86% in 2025.
  • Over the past 5 years, Beam Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.04 in 2021, then increased by 14.85% to 0.05 in 2022, then skyrocketed by 506.87% to 0.27 in 2023, then plummeted by 79.67% to 0.06 in 2024, then fell by 26.17% to 0.04 in 2025.
  • Its Asset Utilization Ratio stands at 0.04 for Q3 2025, versus 0.04 for Q2 2025 and 0.05 for Q1 2025.